The latest fundraise included investors ARK Invest, Founders Fund, G42, Lightspeed, Sequoia Capital and others. Neuralink ...

Smiths has not reported any serious injuries or deaths related to the issues, but the FDA sees a risk of harm.

Freenome plans to complete all modules of its premarket approval submission in mid-2025.

Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with ...